DT-216 | Interleukin Related interleukin-related.com

Product Name :
DT-216

Search keywords :
FXn

drugId :
null

Target Vo:
Frataxin, mitochondrial

Target Vo Short Name :
FXN

Moa_Name:
Frataxin Gene transference

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Design Therapeutics Inc

Active Company_Name :
Design Therapeutics Inc

Active Indication_Name:
Friedreich Ataxia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Pozelimab Data Sheet
Cyclin B1 Rabbit pAb References
HtrA2 Antibody (YA726): HtrA2 Antibody (YA726) is a non-conjugated and Mouse origined monoclonal antibody about 49 kDa, targeting to HtrA2 (8G11). It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts